MatusiakM, SchürchCM: Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics. Respir Res21: 252, 2020PubMed
MatusiakM, SchürchCM: Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics. Respir Res 21: 252, 2020PubMed10.1186/s12931-020-01521-x)| false
GuanW-J, NiZ-Y, HuY, LiangW-H, OuC-Q, HeJ-X, et al.; China Medical Treatment Expert Group for Covid-19: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med382: 1708–1720, 2020PubMed
GuanW-J, NiZ-Y, HuY, LiangW-H, OuC-Q, HeJ-X, ; China Medical Treatment Expert Group for Covid-19: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382: 1708–1720, 2020PubMed10.1056/NEJMoa2002032)| false
ChengY, LuoR, WangX, WangK, ZhangN, ZhangM, et al.: The incidence, risk factors, and prognosis of acute kidney injury in adult patients with coronavirus disease 2019. Clin J Am Soc Nephrol15: 1394–1402, 2020PubMed
ChanL, ChaudharyK, SahaA, ChauhanK, VaidA, ZhaoS, et al.; Mount Sinai COVID Informatics Center (MSCIC): AKI in hospitalized patients with COVID-19. J Am Soc Nephrol32: 151–160, 2021PubMed
ChanL, ChaudharyK, SahaA, ChauhanK, VaidA, ZhaoS, ; Mount Sinai COVID Informatics Center (MSCIC): AKI in hospitalized patients with COVID-19. J Am Soc Nephrol 32: 151–160, 2021PubMed10.1681/ASN.2020050615)| false
ArgenzianoMG, BruceSL, SlaterCL, TiaoJR, BaldwinMR, BarrRG, et al.: Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: Retrospective case series. BMJ369: m1996, 2020PubMed
ArgenzianoMG, BruceSL, SlaterCL, TiaoJR, BaldwinMR, BarrRG, : Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: Retrospective case series. BMJ 369: m1996, 2020PubMed10.1136/bmj.m1996)| false
DellepianeS, VaidA, JaladankiSK, CocaS, FayadZA, CharneyAW, et al.: Acute kidney injury in patients hospitalized with COVID-19 in New York City: Temporal trends from March 2020 to April 2021. Kidney Med3: 877–879, 2021PubMed
DellepianeS, VaidA, JaladankiSK, CocaS, FayadZA, CharneyAW, : Acute kidney injury in patients hospitalized with COVID-19 in New York City: Temporal trends from March 2020 to April 2021. Kidney Med 3: 877–879, 2021PubMed10.1016/j.xkme.2021.06.008)| false
MuruganR, Karajala-SubramanyamV, LeeM, YendeS, KongL, CarterM, et al.; Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators: Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int77: 527–535, 2010PubMed
MuruganR, Karajala-SubramanyamV, LeeM, YendeS, KongL, CarterM, ; Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators: Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 77: 527–535, 2010PubMed10.1038/ki.2009.502)| false
GuptaS, CocaSG, ChanL, MelamedML, BrennerSK, HayekSS, et al.; STOP-COVID Investigators: AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol32: 161–176, 2021PubMed
FlytheJE, AssimonMM, TugmanMJ, ChangEH, GuptaS, ShahJ, et al.; STOP-COVID Investigators: Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis77: 190–203.e1, 2021PubMed
FlytheJE, AssimonMM, TugmanMJ, ChangEH, GuptaS, ShahJ, ; STOP-COVID Investigators: Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis 77: 190–203.e1, 2021PubMed10.1053/j.ajkd.2020.09.003)| false
ChengY, LuoR, WangK, ZhangM, WangZ, DongL, et al.: Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int97: 829–838, 2020PubMed
ChengY, LuoR, WangK, ZhangM, WangZ, DongL, : Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97: 829–838, 2020PubMed10.1016/j.kint.2020.03.005)| false
TaxbroK, KahlowH, WulcanH, FornarveA: Rhabdomyolysis and acute kidney injury in severe COVID-19 infection. BMJ Case Rep 13: e237616, 2020PubMed10.1136/bcr-2020-237616)| false
BatlleD, SolerMJ, SparksMA, HiremathS, SouthAM, WellingPA, et al.; COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group: Acute kidney injury in COVID-19: Emerging evidence of a distinct pathophysiology. J Am Soc Nephrol31: 1380–1383, 2020PubMed
BatlleD, SolerMJ, SparksMA, HiremathS, SouthAM, WellingPA, ; COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group: Acute kidney injury in COVID-19: Emerging evidence of a distinct pathophysiology. J Am Soc Nephrol 31: 1380–1383, 2020PubMed10.1681/ASN.2020040419)| false
SuH, YangM, WanC, YiL-X, TangF, ZhuH-Y, et al.: Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int98: 219–227, 2020PubMed
WichmannD, SperhakeJ-P, LütgehetmannM, SteurerS, EdlerC, HeinemannA, et al.: Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann Intern Med173: 268–277, 2020PubMed
WichmannD, SperhakeJ-P, LütgehetmannM, SteurerS, EdlerC, HeinemannA, : Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann Intern Med 173: 268–277, 2020PubMed10.7326/M20-2003)| false
HuangY, LiX-J, LiY-Q, DaiW, ShaoT, LiuW-Y, et al.: Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: A case report. BMC Nephrol21: 504, 2020PubMed
HuangY, LiX-J, LiY-Q, DaiW, ShaoT, LiuW-Y, : Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: A case report. BMC Nephrol 21: 504, 2020PubMed10.1186/s12882-020-02163-3)| false
LiNL, PapiniAB, ShaoT, GirardL: Immunoglobulin-A vasculitis with renal involvement in a patient with COVID-19: A case report and review of acute kidney injury related to SARS-CoV-2. Can J Kidney Health Dis8: 2054358121991684, 2021PubMed
LiNL, PapiniAB, ShaoT, GirardL: Immunoglobulin-A vasculitis with renal involvement in a patient with COVID-19: A case report and review of acute kidney injury related to SARS-CoV-2. Can J Kidney Health Dis 8: 2054358121991684, 2021PubMed10.1177/2054358121991684)| false
van den AkkerJP, EgalM, GroeneveldAB: Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: A systematic review and meta-analysis. Crit Care17: R98, 2013PubMed
van den AkkerJP, EgalM, GroeneveldAB: Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: A systematic review and meta-analysis. Crit Care 17: R98, 2013PubMed10.1186/cc12743)| false
LongY, SuL, ZhangQ, ZhouX, WangH, CuiN, et al.: Elevated mean airway pressure and central venous pressure in the first day of mechanical ventilation indicated poor outcome. Crit Care Med45: e485–e492, 2017PubMed
LongY, SuL, ZhangQ, ZhouX, WangH, CuiN, : Elevated mean airway pressure and central venous pressure in the first day of mechanical ventilation indicated poor outcome. Crit Care Med 45: e485–e492, 2017PubMed10.1097/CCM.0000000000002290)| false
RanieriVM, SuterPM, TortorellaC, De TullioR, DayerJM, BrienzaA, et al.: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA282: 54–61, 1999PubMed
ParanjpeI, ChaudharyK, JohnsonKW, JaladankiSK, ZhaoS, De FreitasJK, et al.: Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study. PLoS One16: e0247366, 2021PubMed
ParanjpeI, ChaudharyK, JohnsonKW, JaladankiSK, ZhaoS, De FreitasJK, : Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study. PLoS One 16: e0247366, 2021PubMed10.1371/journal.pone.0247366)| false
DellepianeS, MarengoM, CantaluppiV: Detrimental cross-talk between sepsis and acute kidney injury: New pathogenic mechanisms, early biomarkers and targeted therapies. Crit Care20: 61, 2016PubMed
DellepianeS, MarengoM, CantaluppiV: Detrimental cross-talk between sepsis and acute kidney injury: New pathogenic mechanisms, early biomarkers and targeted therapies. Crit Care 20: 61, 2016PubMed10.1186/s13054-016-1219-3)| false
RosasIO, BräuN, WatersM, GoRC, HunterBD, BhaganiS, et al.: Tocilizumab in hospitalized patients with severe covid-19 pneumonia. N Engl J Med384: 1503–1516, 2021PubMed
RosasIO, BräuN, WatersM, GoRC, HunterBD, BhaganiS, : Tocilizumab in hospitalized patients with severe covid-19 pneumonia. N Engl J Med 384: 1503–1516, 2021PubMed10.1056/NEJMoa2028700)| false
NadkarniGN, LalaA, BagiellaE, ChangHL, MorenoPR, PujadasE, et al.: Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol76: 1815–1826, 2020PubMed
KasembeliAN, DuarteR, RamsayM, MosianeP, DickensC, Dix-PeekT, et al.: APOL1 risk variants are strongly associated with HIV-associated nephropathy in black south africans. J Am Soc Nephrol26: 2882–2890, 2015PubMed
KasembeliAN, DuarteR, RamsayM, MosianeP, DickensC, Dix-PeekT, : APOL1 risk variants are strongly associated with HIV-associated nephropathy in black south africans. J Am Soc Nephrol 26: 2882–2890, 2015PubMed10.1681/ASN.2014050469)| false
SuH, WanC, WangZ-D, GaoY, LiY-C, TangF, et al.: Expression of CD147 and cyclophilin A in kidneys of patients with COVID-19. Clin J Am Soc Nephrol16: 618–619, 2020PubMed
SuH, WanC, WangZ-D, GaoY, LiY-C, TangF, : Expression of CD147 and cyclophilin A in kidneys of patients with COVID-19. Clin J Am Soc Nephrol 16: 618–619, 2020PubMed10.2215/CJN.09440620)| false
BeigelJH, TomashekKM, DoddLE, MehtaAK, ZingmanBS, KalilAC, et al.; ACTT-1 Study Group Members: Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med383: 1813–1826, 2020PubMed
BeigelJH, TomashekKM, DoddLE, MehtaAK, ZingmanBS, KalilAC, ; ACTT-1 Study Group Members: Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 383: 1813–1826, 2020PubMed10.1056/NEJMoa2007764)| false
LippiG, SouthAM, HenryBM: Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem 57: 262–265, 202010.1177/0004563220922255)| false
Ruiz-SánchezJG, Núñez-GilIJ, CuestaM, RubioMA, Maroun-EidC, Arroyo-EspligueroR, et al.; HOPE COVID-19 investigators: Prognostic impact of hyponatremia and hypernatremia in COVID-19 pneumonia: A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry analysis. Front Endocrinol (Lausanne)11: 599255, 2020PubMed
FronteraJA, ValdesE, HuangJ, LewisA, LordAS, ZhouT, et al.: Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med48: e1211–e1217, 2020PubMed
FronteraJA, ValdesE, HuangJ, LewisA, LordAS, ZhouT, : Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med 48: e1211–e1217, 2020PubMed10.1097/CCM.0000000000004605)| false
El ShamyO, PatelN, AbdelbasetMH, ChenetL, TokitaJ, LooksteinR, et al.: Acute start peritoneal dialysis during the COVID-19 pandemic: Outcomes and experiences. J Am Soc Nephrol31: 1680–1682, 2020PubMed
